Specialty Research and Innovation
-
Featured
Favipiravir to Treat COVID-19: Q&A with Boris Juelg, MD, PhD
Boris Juelg, MD, PhD, an attending physician in the Division of Infectious Diseases at Massachusetts General Hospital and an assistant professor at Harvard Medical School, explains what is currently known about the drug favipiravir and why he is excited about its potential to treat COVID-19 patients.
-
Featured
Mass General Launching Randomized, Controlled Trial of Tocilizumab for COVID-19
Tocilizumab, a monoclonal antibody that blocks IL-6 already approved in the U.S., might be effective against COVID-19, researchers from Massachusetts General Hospital believe.
-
Featured
Using Chloroquine to Treat COVID-19: Q&A with Raghu Chivukula, MD, PhD
Raghu Chivukula, MD, PhD, a physician-scientist in the Division of Pulmonary and Critical Care Medicine at Massachusetts General Hospital, explains what is currently known about chloroquine and its use to treat COVID-19 patients.
-
Medical Grand Rounds: The MassCPR Program on SARS-CoV-2 Variants of Concern
Jacob Lemieux, MD, DPhil, of the Division of Infectious Diseases, Massachusetts General Hospital, and members of the Massachusetts Consortium on Pathogen Readiness (MassCPR) presented on the SARS-CoV-2 Variants of Concern
-
U.S. COVID-19 Test Results Strongly Correlate with Race/Ethnicity, Income
By reviewing data on 394,536 people tested for COVID-19 before vaccines became available, physicians at Massachusetts General Hospital confirmed that among tested patients, low-income patients and people of color in the US are more likely to have been infected.
-
Plasma sST2 Provides Prognostic Information in COVID-19 Respiratory Failure
Jehan W. Alladina, MD, and Benjamin D. Medoff, MD, of the Division of Pulmonary and Critical Care Medicine, and colleagues advise that high plasma concentrations of soluble suppression of tumorigenicity-2 may signify persistent lung injury in COVID-19 respiratory failure and the need for continued ventilatory support.
Research and Innovation Contributors
-
Andrew T. Chan, MD, MPH
Professor of Medicine, Harvard Medical School, Director for Cancer Epidemiology, Mass General Cancer Center, Chief, Clinical and Translational Epidemiology Unit, Department of Medicine
Recent Article
Research from the Clinical and Translational Epidemiology Unit: The Gut Microbiome
-
Benjamin David Medoff, MD
Chief, Division of Pulmonary and Critical Care, Principal Investigator, Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital
Recent Article
Plasma sST2 Provides Prognostic Information in COVID-19 Respiratory Failure
-
Boris D. Juelg, MD, PhD
Attending Physician, Division of Infectious Diseases, Massachusetts General Hospital, Assistant Professor, Harvard Medical School
Recent Article
Favipiravir to Treat COVID-19: Q&A with Boris Juelg, MD, PhD
-
Bryan Hayes, PharmD, DABAT, FAACT, FASHP
Assistant Professor of Emergency Medicine, Harvard Medical School, Senior Attending Pharmacist, Emergency Medicine and Toxicology, Massachusetts General Hospital
Recent Article
The Use of NSAIDs in COVID-19 Patients: Q&A with Bryan D. Hayes, PharmD -
Charles Corey Hardin, MD, PhD
Physician, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Associate Professor of Medicine, Harvard Medical School, Physician Investigator, Pulmonary, Mass General Research Institute
Recent Article
Persistent Dyspnea After COVID-19 May Have Another Cause
-
David M. Dudzinski, MD
Intensive Care Cardiologist, Massachusetts General Hospital, Director, Cardiac Intensive Care Unit, Associate Editor, Case Records of the MGH
Recent Article
Review: Evidence-Based Management of the Critically Ill Adult with COVID-19
-
Elizabeth Louise Hohmann, MD
Staff Physician, Infectious Diseases Division, Massachusetts General Hospital, Chair and Physician Director, Partners Human Research Committees
Recent Article
Encapsulated Fecal Microbiota Transplantation Alters Gut Microbiome in Adults with Obesity -
Gregory D. Lewis, MD
Section Head, Heart Failure, Director, Cardiopulmonary Exercise Testing Laboratory, Medical Director, Cardiology ICU and Mechanical Circulatory Support Program
Recent Article
Metabolic Cost of Exercise Initiation Higher in HFpEF
-
Guillermo (Gary) Tearney, MD, PhD
Professor of Pathology, Harvard Medical School, Pathologist/Physicist, Massachusetts General Hospital, Faculty, Wellman Center for Photomedicine
Recent Article
MGH Research Scholars Respond to COVID-19 -
Lorenzo Berra, MD
Medical Director, Respiratory Care, Massachusetts General Hospital
Recent Article
COVID-19 ARDS Has Distinct Phenotypes Different from Those in "Classic" ARDS
-
Louise C. Ivers, MD
Interim Director of the Division of Infectious Diseases, Executive Director of the Mass General Center for Global Health
-
Raghu Chivukula, MD, PhD
Physician-Scientist, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital
Recent Article
Review: Evidence-Based Management of the Critically Ill Adult with COVID-19
-
Tomas G. Neilan, MD, MPH
Director, Cardio-Oncology Program, Massachusetts General Hospital, Co-Director, Cardiac MR PET CT Program
Recent Article
T1 Value on Cardiac MRI Diagnoses Myocarditis Associated with Checkpoint Inhibitors
-
Vicki Jackson, MD
Chief, Palliative Care, Massachusetts General Hospital
Recent Article
Massachusetts Trainings Facilitated Nursing Home Staff Resilience, Peer Support During COVID-19
